The master data of products and locations is crucial for providing comprehensive information and historical records of products to achieve complete end-to-end traceability. UniTrace offers multiple interfaces and APIs to import and export accurate and reportable product information seamlessly. Additionally, it allows customers to effortlessly import the digital representation of their supply chain by importing location master data, facilitating seamless connections with both external and internal supply chain partners, and establishing a clear path for capturing the journey of the products.
UniTrace records and archives the complete history of each item by leveraging the four dimensions of EPCIS events: What, Where, When, and Why. These EPCIS events enable comprehensive documentation of the sequence of actions and status changes for each item as it progresses through the supply chain, starting from raw materials or the manufacturing stage to the final sale or distribution. UniTrace is fully compatible with EPCIS 1.0, 1.1, 1.2, and is prepared for EPCIS 2.0, offering a fully customizable interface that empowers our clients to expand the Core Business Vocabulary with tailored business steps. Additionally, UniTrace is compatible with GS1 Digital Link, supporting both URN and DL URIs.
The UniTrace NRM encompasses the establishment, reception, dissemination, and centralized administration of serialized numbers to process serialized entities at both site and enterprise levels. Within its database, UniTrace can generate serial numbers. These numbers can be generated through a REST API request, or UniTrace can source them from an external system or entity, such as a government agency. UniTrace supports the following types of pools:
Effortlessly import your location master data for seamless connections with all your partners. Speak with an expert now!
Learn how using open, global and proven standards can improve pharma supply chain
Takeaways from the recent 2024 FDLI Annual Conference with focus on readiness for DSCSA…
Rising numbers of counterfeit drugs are entering pharmaceutical supply chains…